Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer (Q80951687)
Jump to navigation
Jump to search
scientific article published on 26 March 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer |
scientific article published on 26 March 2008 |
Statements
Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer (English)
M Ruiz
J Salvador
J Bayo
M Lomas
A Moreno
M Valero
R Bernabé
D Vicente
J Jiménez
A Lopez-Ladrón